GeneOne Life Science, Inc.

KOSE:A011000 Voorraadrapport

Marktkapitalisatie: ₩171.2b

GeneOne Life Science Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Young-Keun Park

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO9.0%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

The Market Doesn't Like What It Sees From GeneOne Life Science, Inc.'s (KRX:011000) Revenues Yet As Shares Tumble 39%

Sep 09
The Market Doesn't Like What It Sees From GeneOne Life Science, Inc.'s (KRX:011000) Revenues Yet As Shares Tumble 39%

Is GeneOne Life Science (KRX:011000) Using Too Much Debt?

Aug 31
Is GeneOne Life Science (KRX:011000) Using Too Much Debt?

Why Investors Shouldn't Be Surprised By GeneOne Life Science, Inc.'s (KRX:011000) Low P/S

Jul 26
Why Investors Shouldn't Be Surprised By GeneOne Life Science, Inc.'s (KRX:011000) Low P/S

Is GeneOne Life Science (KRX:011000) Using Debt In A Risky Way?

Mar 20
Is GeneOne Life Science (KRX:011000) Using Debt In A Risky Way?

GeneOne Life Science (KRX:011000) Has Rewarded Shareholders With An Exceptional 855% Total Return On Their Investment

Jan 10
GeneOne Life Science (KRX:011000) Has Rewarded Shareholders With An Exceptional 855% Total Return On Their Investment

CEO

Young-Keun Park (60 yo)

no data

Tenure

Mr. Young-Keun Park, J.D., MBA, is the Chief Executive Officer of at GeneOne Life Science, Inc. and served as its director and President. He serves as Director at GeneOne Life Science, Inc. Mr. Park is the...